Single Cross-Sectional Analysis; Post-Myocardial Infarction Instrumental & Laboratory changes in Prognosis Behavior - Marzoog, Basheer Abdullah; Bloshkina, Natalia Igorevna; Gromova, Vera Sergeevna; Vanichkina, Ekaterina; Gorshinina, Elena Ivanovna (medRxiv, 2023)
Background Cardiovascular events remain one of the frequently reported causes of death globally.Aims Assess the early laboratory and instrumental changes in systemic manner in patients with myocardial infarction (MI).Objectives Patients with fresh myocardial infarction that has been occurred in less than 30 days before hospitalization in the rehabilitation hospital.Materials and methods A single large-scale retrospective cohort sectional study for patients with fresh myocardial infarction for the period 2014-2019, data collected from Mordovia Rehabilitation Hospital. The study involved 154 patients and analysed 76 parameters for each patient. The t test, Pearson’s correlation coefficient, and ROC test have been used. For statistical analysis used Statistica program.Results The sample included 154 patients with a history of fresh myocardial infarction. Of 154. 51(33.11%) female and 103 (66.88 %) males. Chronic heart failure (CHF), which is seen in 42 (27.27 %) patients, 101 (65.58 %) did not have CHF and 11 (7.142 %) missing data. Diabetes mellitus (DM) has been observed in 28 (18.18182 %), 118 (76.62 %) without DM, Hypertension has been seen in 118 (76.62 %), 28 (18.18 %) did not have hypertension, chronic kidney disease (CKD) has been seen in 11 (7.14%) patients, 131 (85.064 %) did not have CKD, Chronic obstructive pulmonary disease (COPD) existed in 14 (9.09 %), 132 (85.71 %) did not have COPD. Post myocardial infarction (MI) CHF has been observed in 108 (70.12987%), 42 (27.27 %) did not have CHF. Post MI arrythmia seen in 50 (32.47%) patients, 99 (64.28 %) did not have arrythmia. Early post MI complication such as aneurysm has been seen in 12 (7.79 %), 138 (89.61 %) did not have aneurysm, Dressler syndrome; pericarditis has been seen in 4 (2.59 %) patients, pneumonitis seen in 1 (0.64 %) patient, and pleuritis have not been seen.Conclusions Systemic manifestations include kidney function impairment or development of new kidney disease. These changes include an increase in the aorta basement diameter, an increase in the right ventricle size, a decrease in the level of serum red blood cells, the serum potassium level, and serum calcium level, with an increase in the serum myoglobin. The high myoglobin level is associated with the development of chronic heart failure. The higher creatinine level and or LDH is associated with arrythmia development. Hypertension is the predominant concomitant disease in victims of MI. And arrythmia is most commonly reported post-MI complication.Others Females are more frequently affected by post-MI urinary tract infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work of Basheer Abdullah Marzoog was financed by the Ministry of Science and Higher Education of the Russian Federation within the framework of state support for the creation and development of World-Class Research Center Digital biodesign and personalized healthcare № 075-15-2022-304.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study approved by the National Research Mordovia State University6 Russia, from Ethics Committee Requirement N8/2 from 30.06.2022.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsCHFchronic heart failure,DMDiabetes mellitus,CKDChronic kidney disease,COPDChronic obstructive pulmonary disease,MImyocardial infarction,HRheart rate,ESRerythrocytes sedimentation rate,RBCred blood cells